Re takeovers,
It is common practice commission an independent valuation report as part of a takeover. It is also rare for boards to recommend a takeover if the bid price is below the bottom of the independent valuation range. A number of games can be played on how that independent valuation range is determined, but it is supposed to be a comprehensive independent review.
Some of the items that would make it difficult to write an low-ball independent valuation report are:
- The current 44% Mn price is above the PFS estimates.
- Strong internal documentation should exist around smelter credits.
- The PFS only used the 50.6Mt of proved and probable resources. The remaining 212Mt of inferred resource is not part of the original NPV and has some value.
- The expansion study suggesting a low capex improvement in the project after-tax NPV from A$421m to A$798m. This increase occurred by bringing forward the production timeline of the 50.6Mt. It didn't include any value to the other 212Mt of ore.
- The HP scoping study suggested an after-tax NPV of US$395m to US$1,142m (50kt / 150kt capacity).
- Out year optionality would exist for further expansions.
- Any non-published internal material that has been written towards a HP feasibility study and any early work on a DFS
- Needing to attribute at least some value to lithium prospects (tenements are held with good geological characteristics)
- The October 2021 Petra capital research report indicating a A$3.98 value (and one poster indicated a new report is >A$5)
Despite the supposed if not probable valuation gap, an agreed takeover would be difficult becase a low-ball offer would likely stall on the valuation report. Hostile takeovers aren't that common and I doubt big players would go down a hostile takeover for a small entity like E25. I could however see management recommending a HP JV. It would take some potential value off the table for E25 shareholders, but it would materially improve the likelihood of the HP project proceeding in a timely manner.
- Forums
- ASX - By Stock
- The Dawn of EV
E25
element 25 limited
Add to My Watchlist
7.14%
!
22.5¢

Re takeovers,It is common practice commission an independent...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.015(7.14%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 21.5¢ | $36.91K | 166.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11163 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 101483 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11163 | 0.220 |
4 | 65606 | 0.215 |
4 | 14875 | 0.210 |
1 | 3107 | 0.205 |
8 | 89405 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 101483 | 3 |
0.230 | 72958 | 1 |
0.235 | 124800 | 3 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online